Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.63 |
| ▸ | HPGD | P15428 | 6/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.62 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.62 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.62 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | GGT1 | P19440 | 1/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | CDC25B | P30305 | 1/20 | 0.59 |
| ▸ | CTSD | P07339 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29365231 | 0.98 | HTT (0.78) | HTTKMT2AKDM4EHPGDHSD17B10 | |
| SCHEMBL3527 | 0.98 | HTT (0.78) | HTTKMT2AKDM4EHPGDHSD17B10 | |
| Bicarbonate SCHEMBL238308 | 0.96 | HTT (0.75) | HTTKMT2AKDM4EHPGDHSD17B10 | |
| Fluoride SCHEMBL3190250 | 0.96 | HTT (0.75) | HTTKMT2AKDM4EHPGDHSD17B10 | |
| Bicarbonate SCHEMBL29943714 | 0.96 | HTT (0.75) | HTTKMT2AKDM4EHPGDHSD17B10 | |
| Hydrochloric Acid SCHEMBL4236548 | 0.96 | HTT (0.75) | HTTKMT2AKDM4EHPGDHSD17B10 | |
| SCHEMBL10404879 | 0.96 | HTT (0.75) | HTTKMT2AKDM4EHPGDHSD17B10 | |
| Bicarbonate SCHEMBL21517635 | 0.96 | HTT (0.75) | HTTKMT2AKDM4EHPGDHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL22437491 | 0.96 | HTT (0.75) | HTTKMT2AKDM4EHPGDHSD17B10 | |
| Hydrochloric Acid SCHEMBL27624365 | 0.96 | HTT (0.75) | HTTKMT2AKDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024106739-A1 | COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, COMPOUND FOR PREVENTION, ALLEVIATION, OR TREATMENT OF GLIOBLASTOMA | 주식회사 힐리노엘에스 | 2024-05-23 | — | — | WO | claimed |
| WO-2023210882-A1 | COMPOSITION FOR BOOSTING IMMUNITY AND PREVENTING, AMELIORATING, OR TREATING PARKINSON'S DISEASE, COMPRISING O-CYCLIC PHYTOSPHINGOSINE-1-PHOSPHATE DERIVATIVE AS ACTIVE INGREDIENT | 경상국립대학교산학협력단 | 2023-11-02 | — | — | WO | claimed |
| WO-2023158024-A1 | COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE COMPRISING ISODON EXCISUS (MAX.) KUDO-DERIVED COMPOUND AS ACTIVE INGREDIENT | 주식회사 힐리노엘에스 | 2023-08-24 | — | — | WO | claimed |
| WO-2024106739-A1 | COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, COMPOUND FOR PREVENTION, ALLEVIATION, OR TREATMENT OF GLIOBLASTOMA | 주식회사 힐리노엘에스 | 2024-05-23 | — | — | WO | disclosed |
| WO-2023210882-A1 | COMPOSITION FOR BOOSTING IMMUNITY AND PREVENTING, AMELIORATING, OR TREATING PARKINSON'S DISEASE, COMPRISING O-CYCLIC PHYTOSPHINGOSINE-1-PHOSPHATE DERIVATIVE AS ACTIVE INGREDIENT | 경상국립대학교산학협력단 | 2023-11-02 | — | — | WO | disclosed |
| WO-2023158024-A1 | COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE COMPRISING ISODON EXCISUS (MAX.) KUDO-DERIVED COMPOUND AS ACTIVE INGREDIENT | 주식회사 힐리노엘에스 | 2023-08-24 | — | — | WO | disclosed |
| EP-3154516-B1 | STABILIZED DESMOPRESSIN | FERRING BV (NL) | 2019-09-04 | — | — | EP | disclosed |
| US-20170136025-A1 | PHARMACEUTICAL PREPARATION CONTAINING ENTECAVIR AS ACTIVE INGREDIENT, AND PREPARATION METHOD THEREFOR | CTC BIO, INC. (KR) | 2017-05-18 | — | — | US | disclosed |
| US-20170128521-A1 | STABILIZED DESMOPRESSIN | CTCBIO INC. (KP) | 2017-05-11 | — | — | US | disclosed |
| EP-3158998-A1 | PHARMACEUTICAL PREPARATION CONTAINING ENTECAVIR AS ACTIVE INGREDIENT, AND PREPARATION METHOD THEREFOR | CTC Bio, Inc. (KR) | 2017-04-26 | — | — | EP | disclosed |
| EP-3154516-A1 | STABILIZED DESMOPRESSIN | Ferring BV (NL) | 2017-04-19 | — | — | EP | disclosed |
| WO-2015193246-A1 | STABILIZED DESMOPRESSIN | FERRING B.V. (NL) | 2015-12-23 | — | — | WO | disclosed |
| WO-1998008508-A1 | USE OF PKC INHIBITORS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HTLV-1 INFECTIONS | ELI LILLY AND COMPANY (US) | 1998-03-05 | — | — | WO | disclosed |